BriaCell Therapeutics - Warrants (24/02/2025) Overview

BriaCell Therapeutics - Warrants (24/02/2025) Research & Development

Research & Development expenses for BCTXW.

Quarterly R&D Expenses

$5.97M

↑ 24.04% YoY

As of Apr 30, 2026

Annual R&D Expenses (TTM)

$25.81M

↑ 39.04% YoY

Trailing 12 months ending Apr 30, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin